Additionally, samples exhibited enhanced figure of merit over that of classic state-of-the art Si/Ge, improvements as large as 30% were obtained for both p-type and n-type samples.
Accordingly, the pharmacokinetics and tumour uptake of the new ligands, i.e. 68Ga-12 in LNCaP-tumour bearing CD-1 nu/nu mice could be enhanced (Figure 7).
For the HT-170 NPs, the PL peak at 560 nm decreased, while that at 464 nm to approximately 516 nm was considerably enhanced (Figure 2b).
However, when NaClO solution of 1.27 × 10-2 mol/L was mixed with the CdTe, and then injected into the stream, the CL signal was greatly enhanced (Figure 2a).
Meanwhile, the effective lifetime of the sample annealed at 300°C was slightly enhanced (Figure 2), i.e., 1.2 times greater than that of the as-deposited sample.
The catalytic activity of recombinant β-xylosidase was measured using 1 mM pNPX as substrate in the presence of 20 mM sugar solutions to test whether the enzyme was inhibited or enhanced (Figure 3A).
By BP102 staining, abnormalities in the spacing between adjacent segments was also enhanced (Figure 3J).
Correspondingly, levels of cell cycle and replication proteins were dramatically enhanced (Figure 2C, right panel).
Specifically, the tumor suppressor gene PTEN was down-regulated whereas AKT phosphorylation was enhanced (Figure 3B).
As F-actin content in general was enhanced (Figure 3A, 3F), analysis of the actin depolymerization/polymerization cycle was performed.
